Yamamoto JK - Search Results

1

Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.

Sahay B, Aranyos AM, Mishra M, McAvoy AC, Martin MM, Pu R, Shiomitsu S, Shiomitsu K, Dark MJ, Sanou MP, Roff SR, Rathore MH, Yamamoto JK. Sahay B, et al. Among authors: yamamoto jk. Viruses. 2019 Feb 3;11(2):136. doi: 10.3390/v11020136. Viruses. 2019. PMID: 30717485 Free PMC article.

2

Experimental vaccine protection against feline immunodeficiency virus.

Yamamoto JK, Okuda T, Ackley CD, Louie H, Pembroke E, Zochlinski H, Munn RJ, Gardner MB. Yamamoto JK, et al. AIDS Res Hum Retroviruses. 1991 Nov;7(11):911-22. doi: 10.1089/aid.1991.7.911. AIDS Res Hum Retroviruses. 1991. PMID: 1662057

3

Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.

Pu R, Okada S, Little ER, Xu B, Stoffs WV, Yamamoto JK. Pu R, et al. Among authors: yamamoto jk. AIDS. 1995 Mar;9(3):235-42. AIDS. 1995. PMID: 7755911

4

Superinfection of cats with feline immunodeficiency virus subtypes A and B.

Okada S, Pu R, Young E, Stoffs WV, Yamamoto JK. Okada S, et al. Among authors: yamamoto jk. AIDS Res Hum Retroviruses. 1994 Dec;10(12):1739-46. doi: 10.1089/aid.1994.10.1739. AIDS Res Hum Retroviruses. 1994. PMID: 7888234

5

Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus.

Yamamoto JK, Hohdatsu T, Olmsted RA, Pu R, Louie H, Zochlinski HA, Acevedo V, Johnson HM, Soulds GA, Gardner MB. Yamamoto JK, et al. J Virol. 1993 Jan;67(1):601-5. doi: 10.1128/JVI.67.1.601-605.1993. J Virol. 1993. PMID: 8380095 Free PMC article. Clinical Trial.

6

Passive antibody protection of cats against feline immunodeficiency virus infection.

Hohdatsu T, Pu R, Torres BA, Trujillo S, Gardner MB, Yamamoto JK. Hohdatsu T, et al. Among authors: yamamoto jk. J Virol. 1993 Apr;67(4):2344-8. doi: 10.1128/JVI.67.4.2344-2348.1993. J Virol. 1993. PMID: 8383246 Free PMC article.

7

Mechanism(s) of FIV vaccine protection.

Pu R, Tellier MC, Yamamoto JK. Pu R, et al. Among authors: yamamoto jk. Leukemia. 1997 Apr;11 Suppl 3:98-101. Leukemia. 1997. PMID: 9209311

8

Development of FIV-specific cytolytic T-lymphocyte responses in cats upon immunisation with FIV vaccines.

Tellier MC, Soos J, Pu R, Pollock D, Yamamoto JK. Tellier MC, et al. Among authors: yamamoto jk. Vet Microbiol. 1997 Jun 30;57(1):1-11. doi: 10.1016/s0378-1135(97)00081-3. Vet Microbiol. 1997. PMID: 9231977

9

Perspectives on FIV vaccine development.

Elyar JS, Tellier MC, Soos JM, Yamamoto JK. Elyar JS, et al. Among authors: yamamoto jk. Vaccine. 1997 Aug-Sep;15(12-13):1437-44. doi: 10.1016/s0264-410x(97)00056-x. Vaccine. 1997. PMID: 9302758 Review.

10

Effect of dual-subtype vaccine against feline immunodeficiency virus infection.

Hohdatsu T, Okada S, Motokawa K, Aizawa C, Yamamoto JK, Koyama H. Hohdatsu T, et al. Among authors: yamamoto jk. Vet Microbiol. 1997 Nov;58(2-4):155-65. doi: 10.1016/s0378-1135(97)00164-8. Vet Microbiol. 1997. PMID: 9453127 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters